by | Jan 12, 2026 | Ly, Amy, Maher, Christopher, Maher, Nicole, Nickless, Andrew, Webster, Jace, Zhang, Jin
— Published date: 1/13/2026
Value Proposition: Predictive biomarkers that can identify patients that would respond well to HER2 targeted breast cancer treatment that are not currently being treated this way.
Technology Description
Researchers at Washington University in St. Louis have establis…
by | Jan 3, 2025 | Blake, Kevin, Dantas, Gautam, DeAngelo, Caitlin, Wencewicz, Timothy, Williford, Emily
— Published Date: 1/4/2025
Value Proposition: New composition of matter that combines tetracycline class compounds with destructase inhibitors to overcome resistance to tetracycline antibiotics.
Technology Description
Researchers at Washington University in St. Louis have developed an enzymatic…
by | Jan 3, 2025 | Dantas, Gautam, Forsberg, Kevin, Gasparrini, Andrew, Park, Jooyoung, Tolia, Niraj, Vogel, Joseph, Wencewicz, Timothy
— Published Date: 1/4/2025
Value Proposition: New composition of matter that combines tetracycline class compounds with destructase inhibitors to overcome resistance to tetracycline antibiotics.
Technology Description
Researchers at Washington University in St. Louis have developed an enzymatic…
by | Dec 18, 2024 | Kim, Taeho
— Published Date: 12/18/2024
Value Proposition: First clinical application of super resolution (SR) MRI reconstruction for 2D cine MRI in real-time radiotherapy.
Technology Description
Researchers at Washington University in St. Louis have developed a novel application for super-resolution (SR) c…
by | Dec 18, 2024 | Kim, Taeho, Schmidt, Matthew
— Published Date: 12/19/2024
Value Proposition: First clinical application of super resolution (SR) MRI reconstruction for 2D cine MRI in real-time radiotherapy.
Technology Description
Researchers at Washington University in St. Louis have developed a novel application for super-resolution (SR) c…